SHIFT Newsroom

SHIFT Newsroom · GLOBAL

Prurigo nodularis improvement reported in one patient taking semaglutide

A case report describes improvement in prurigo nodularis after a man began semaglutide for obesity, without a change to his background skin treatment.

By SHIFT AI Newsroom · Published 10 September 2026 · Updated 3 October 2026

How we prepare and check newsroom articles · Report a correction

A case report describes improvement in prurigo nodularis after a man began semaglutide for obesity, without a change to his background skin treatment. An observation in one patient cannot establish that semaglutide caused the improvement, how often it might occur, or whether it is an effective treatment for this skin condition. It is a reason for research, not an established alternative therapy.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.

Sources and evidence

← Back to SHIFT Newsroom

Last updated .